Infliximab-induced psoriasis in a patient with crohn′s disease

Infliximab-induced psoriasis in a patient with crohn′s disease

Infliximab is a well-known treatment for inflammatory bowel diseases (IBDs) and psoriasis. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor necrosis factor-α antagonist therapy in patients with IBD. Here, we report a case with Crohn′s disease who developed Infli...

Full description

Bibliographic Details
Main Authors: Iqbal Bukhari, Nasser Alzoubi, Abdulaziz A Al-Quorain
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Saudi Journal of Medicine and Medical Sciences
Subjects:
Biological therapy
Crohn′s disease
Infliximab
psoriasis
tumor necrosis factor-alpha inhibitors
Online Access:http://www.sjmms.net/article.asp?issn=1658-631X;year=2015;volume=3;issue=1;spage=81;epage=83;aulast=Bukhari

Internet

http://www.sjmms.net/article.asp?issn=1658-631X;year=2015;volume=3;issue=1;spage=81;epage=83;aulast=Bukhari

Similar Items